WELLINGTON MANAGEMENT GROUP LLP

Position in TNDM — Tandem Diabetes Care Inc

CIK 902219 Boston, MA

Position in TNDM

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$19,989,784

+$17,828,953 QoQ

Shares Held

1,042,764

+960.7% QoQ

Ownership

1.52%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 0% Shared 79% None 21%

Healthcare · as of Mar 31, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $10,802,033,266 across 28 Medical Devices names. TNDM ranks #15 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	27,070,518	$2,779,330,079
2	SYK	Stryker Corp	8,121,707	$2,668,711,698
3	EW	Edwards Lifesciences Corp	22,011,101	$1,762,648,965
4	BSX	Boston Scientific Corp	18,833,406	$1,181,796,224
5	MDT	Medtronic plc	7,525,572	$652,090,810
6	STE	STERIS plc	2,873,365	$635,387,197
7	DXCM	Dexcom Inc	9,326,240	$585,687,870
8	INSP	Inspire Medical Systems, Inc.	2,535,954	$130,804,505

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$19,989,784	1,042,764	+960.7%	Shares	Defined	2026-05-15
2025-12-31	$2,160,831	98,309	-70.1%	Shares	Defined	2026-02-17
2022-09-30	$15,736,237	328,866	-51.9%	Shares	Defined	2022-11-14
2022-06-30	$40,452,753	683,439	-2.4%	Shares	Defined	2022-08-15
2022-03-31	$81,462,888	700,515	-1.1%	Shares	Defined	2022-05-16
2021-12-31	$106,660,728	708,615	+54.5%	Shares	Defined	2022-02-11
2021-09-30	$54,752,322	458,639	-18.3%	Shares	Defined	2021-11-15
2021-06-30	$54,648,899	561,077	+2.4%	Shares	Defined	2021-08-16
2021-03-31	$48,355,616	547,939	-75.8%	Shares	Defined	2021-05-17
2020-12-31	$216,661,041	2,264,434	-37.6%	Shares	Defined	2021-02-12
2020-09-30	$411,953,356	3,629,545	-41.8%	Shares	Defined	2020-11-16
2020-06-30	$617,046,930	6,237,838	-8.1%	Shares	Defined	2020-08-14
2020-03-31	$436,809,211	6,788,022	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.